The University Hospital of North Norway or UNN is a hospital and health trust. UNN is a university hospital for the region which includes the counties of Nordland, Troms and Finnmark. It is part of the Northern Norway Regional Health Authority. Its service area has a combined population of 465,000.

During the past decade, Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge" #1 collaborator was "Janssen-Cilag Ltd." with 1 trials as a collaborator and "Nordic Cancer Union" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge" in a lesser frequency.

Most popular intervention types in "Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "bortezomib" (1 trials) and "pamidronate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Med avd B, Hematologisk seksjon, Universitetssykehuset Nord Norge, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".